Pharma's Almanac TV
PA TV
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Follow the Journey
Companies On The Road
Arcadis DPS Group
C2 Pharma
CAI
EcoLab
Environmental Systems Corporation
Federal Equipment Company
Globyz Biopharma Services
Grifols
Integrity
Nu-Tek BioSciences
PHARMALEX
Waters Corporation
Follow the Completed Journey
Companies On The Road
Follow The Artist
ABS
aCGT Vector
Alconox Inc.
Andelyn Biosciences
Arranta Bio
Avid Bioservices
BDD
BIOVECTRA
DPS Group
Dynamk Capital
Environmental Systems Corporation
Federal Equipment Company
Genesis AEC
Globyz Biopharma Services
Grifols Partnership
IDT Biologika
Inceptor Bio
IPS-Integrated Project Services
Kineticos Life Sciences
MilliporeSigma
Montana BioScience Alliance
Olon
Rentschler Biopharma
SanaClis
Scorpion Biological Services
Secant Group
Tapemark
VITRONIC
Follow the Completed Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Archive
Reports
2023 Nice Insight Reports
Cell & Gene Therapy: 2023 Market Analysis, CDMO Pricing and Benchmarking
Monoclonal Antibody & Recombinant Protein: 2023 Market Analysis, CDMO Pricing and Benchmarking
mRNA Vaccines & Therapeutics: 2023 Market Analysis, CDMO Pricing and Benchmarking
Sterile Drug Product: 2023 Market Analysis, CDMO Pricing and Benchmarking
Active Pharmaceutical Ingredients: 2023 Market Analysis, CDMO Pricing and Benchmarking
Antibody Drug Conjugates: 2023 Market Analysis, CDMO Pricing and Benchmarking
Contract Research Organizations: 2023 Market Analysis, Pricing and Benchmarking
Oral Solid Dosage: 2023 Market Analysis, CDMO Pricing and Benchmarking
Community
Company A to Z
Follow the Journey
Companies On The Road
Follow The Artist
Follow the Journey
Companies On The Road
More+
Staffing
Media Kit
Investment
218 Articles Available
1
10
Can't find what you're looking for? Try our
advanced search
.
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
PR-M10-23-03
mRNA Manufacturing
Investing in the Future of mRNA Manufacturing
PAO-11-022-CL-02
Investment
Orgenesis Secures up to USD 50 Million Subsidiary-Level Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Services
PR-M11-22-05
Warehouse Storage
New Fully Automated Vetter Warehouse Expands Storage and Boosts Logistical Infrastructure
PR-M10-22-07
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
PR-M09-22-02
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
PR-M09-22-01
New Division
Olon Presents Olon Biotech, A New Division Operating by Biotechnological Processes
PR-M07-22-03
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
PAO-06-022--NI-12
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
PAO-06-022--NI-02
mRNA Manufacturing
Vernal Biosciences Raises $21 Million to Accelerate mRNA Manufacturing Growth
PR-M06-22-01
Decentralized Clinical Trials
uMotif – The Patient-First Data Capture and Decentralized Clinical Trials Platform – Announces $25.5m of New Investment from a Fund Managed by Athyrium Capital Management
PR-M05-22-13
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
PAO-05-22-R250-09
Spray Drying
Olon Invests in New Spray Dryer at Rodano R&D Centre
PR-M05-22-11
Investment
Bringing Value to Pharma and Biopharma
PAO-04-22-R250-75
Investment
Driving Transformational Change in the Middle Market
PAO-04-22-R250-65
Investment
Global Investment Trends and Getting Noticed by PE/VC Firms
PAO-02-022-CL-15
Investment
Focusing on the Potential of Midsized Pharma Service Organizations
PAO-03-22-R250-03
Investment
Investment Opportunities in the Medical Device Sector
PAO-03-22-R250-01
Private Equity
Supporting Growth for Middle-Market Companies
PAO-02-22-R250-22
Biopharmaceutical Manufacturing
Investing and Expanding for High-Quality Biopharmaceuticals
PAO-02-22-R250-19
Facility Acquisition
MilliporeSigma Announces Closing of Exelead Acquisition and Plans to Invest More Than € 500 Million in Technology Scale-Up
PR-M02-22-20
Consulting
Helping Biopharma Companies Grow with Insight
PAO-01-22-R250-17
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
PR-M01-22-13
Cell and Gene Therapy
Supporting Innovative Biotechs to Bring Cell and Gene Therapies to Market
PAO-11-21-CL-15
1
10
»
